Mariner, LLC Cytosorbents Corp Transaction History
Mariner, LLC
- $58.8 Billion
- Q1 2025
Shares
3 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.29 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$2.55 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.66 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.43 Million0.0% of portfolio
-
Cm Management, LLC954KShares$810,9641.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...